Fractional CO2 laser for postmenopausal vaginal symptoms - a follow-up study

Not Applicable

Recruiting

• Conditions: Postmenopausal vaginal symptoms; Postmenopausal symptoms; Genitourinary syndrome of menopause; Atrophic vaginitis; Reproductive Health and Childbirth - Menstruation and menopause; Renal and Urogenital - Normal development and function of male and female renal and urogenital system

• Registration Number: ACTRN12621000361808
• Lead Sponsor: GRACE Unit - School of Women's and Children's Health, UNSW Sydney, Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-30
• Last Update Posted: 21 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

Symptomatic women with 1 AND 2 or 3

1. Previously participated in the double blind placebo-controlled randomised trial of fractional CO2 laser
AND
---
2. Post-menopausal women who have not had a menstrual period for at least 12 months (with an intact uterus) and/or have vulvovaginal symptoms substantial enough for them to present to their health care provider due to symptoms
OR
3. Women who have previously had a hysterectomy and have vaginal atrophy symptoms and have an elevation of FSH (>30) consistent with a post-menopausal state.

Exclusion Criteria

1. Current urinary tract infection.
2. Active genital infections.
3. Current genital herpes infection.
4. Pelvic organ prolapse (most substantial prolapse) POPQ system stage 2.
5. Previous vaginal prolapse surgery where there is mesh repair in the pelvis.
6. Chronic disease states which will interfere with compliance to study

Study & Design

• Study Type: Interventional
• Study Design: Not specified